IP Verse

Use Of Eicosapentaenoic Acid Ethyl Ester For Treating Hypertriglyceridemia

Patent No. EP2596786 (titled "Use Of Eicosapentaenoic Acid Ethyl Ester For Treating Hypertriglyceridemia") was filed by Amarin Pharmaceuticals Ireland on Feb 9, 2010. The application was issued on Nov 27, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HOFFMANN EITLEAug 26, 2020HOFFMANN EITLE
ELKINGTON AND FIFEAug 25, 2020ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2596786

AMARIN PHARMACEUTICALS IRELAND
Application Number
EP13156122A
Filing Date
Feb 9, 2010
Status
Revoked
Oct 7, 2022
Publication Date
Nov 27, 2019
External Links
Slate, Register , Google Patents